Scalper1 News
Diagnostic testing company Bio-Reference Laboratories (BRLI) on Wednesday slashed its profit guidance for the quarter and year, sending shares crashing 20% in morning trading on the stock market today. Bio-Reference stock had risen nearly 35% from Oct. 8 through Tuesday. The company says it expects to report revenue for its fiscal Q4 ended Oct. 31 of about $192 million, which actually is higher than analysts’ consensus of $189 million, according Scalper1 News
Scalper1 News